The European Society for Medical Oncology (ESMO) released today the ESMO Guidance on the Use of Large Language Models in ...
Natera has announced positive results from the Phase III IMvigor011 clinical trial for muscle-invasive bladder cancer (MIBC).
SciTech Development, Inc., a clinical-stage oncology company advancing nanotechnology-enabled cancer therapeutics, today ...
TipRanks on MSN
Kura Oncology announces preliminary data from FTI programs
Kura Oncology (KURA) announced new preliminary data from its farnesyl transferase inhibitor, FTI, programs – darlifarnib and tipifarnib – ...
(NASDAQ:MRNA) today announced that clinical, safety and translational data from its Phase 1/2 study evaluating mRNA-4359 in ...
The state-of-the-workforce report identifies challenges in cancer care access across the US, particularly in rural areas.
(UroToday.com) The 2025 European Society for Medical Oncology (ESMO) Annual Congress was host to a radioligand therapeutics proffered paper session. Dr. Karolien Goffin discussed the previously ...
The ELCAP guidance sets standards for responsible AI use in oncology, protecting patients and supporting clinicians LUGANO, Switzerland and BERLIN, Oct. 20, 2025 /PRNewswire/ ...
Dr. Laurence Albiges presented the poster Characteristics and real-world adherence to ESMO guidelines of patients with advanced Renal Cell Carcinoma (aRCC) in the era of immuno-oncology-based (IO) ...
At 72, Judith McDaniel, a former oncology nurse, experienced cancer treatment after a routine mammogram led to her diagnosis ...
Dr. Hyatt “Tracy” DeGreen carries on his father’s legacy at Lancaster Cancer Center, offering compassionate, patient-first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback